the WTO has allowed poor countries to import cheap drugs

the WTO has allowed poor countries to import cheap drugsThe General Council of the world trade organization (WTO) in Geneva approved an agreement that will allow poor countries to import cheap drugs for AIDS and tuberculosis. The agreement called one of the most important decisions of the WTO. The liberalization of the patent rules, the approved agreement will enable poor countries to buy and to produce cheaper versions of the most effective drugs to combat serious diseases. Until recently, the main obstacle to the adoption of the agreement was the position of the United States, declaring that the refusal of patents undermine the position of the large pharmaceutical companies working on the creation of new medicines. Many effective drugs patents are valid for 20 years that prohibits them up in the form of cheaper "generic" forms. The principle, according to which developing countries would get access to cheap medicines against AIDS, malaria, tuberculosis and other serious diseases, was developed two years ago. But the details of it were developed very slowly. So, in December, the U.S. has blocked one of the projects agreement, stating that it allows you to withdraw from under the patent law too many kinds of medicines, such as medicines for non-communicable diseases, such as diabetes or asthma. This week, the United States agreed to relax the requirements on the protection of patents on medicines. The agreement on the liberalization of the patent rules Washington requires WTO members not to abuse the new rules: not to resort to unpatentable production of medicines "for reasons of the highest order", and not for commercial gain. Developing countries also expect the adoption of measures that will not allow more cheap forms of the drugs to penetrate the markets of rich countries. A large pharmaceutical company welcomed the compromise achieved. However, representatives of non-governmental organizations believe that a new document entangles Third world countries dense network of reservations and conditions and in practice does not facilitate the situation with the treatment of severe diseases. African activists said that the US still bowed governments of Third world countries to sign the agreement, which still keeps the price of drugs at an unacceptably high level. Criticized the results of the Geneva meeting and the representatives of India, which produces many of the medicines copies. Representatives of large companies explain the need for strong patent restrictions increasing cost of research prior to the creation of highly effective drugs. According to them, the pharmaceutical firms - primarily commercial enterprises, are required to balance the cost of production of drugs with the proceeds from their sale.

Похожие статьи

Ваше имя
Ваша почта
Город, область
Рассылка комментариев

Ввести код: